CAS: 2505001-62-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (E)-3-(3,4-Dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide REF: IN-DA01XBU4CAS: 2505001-62-5 | 95% | To inquire | Wed 11 Dec 24 |
 | SR18662 free base REF: TM-T9307CAS: 2505001-62-5 | 98.97% | - - - | Discontinued product |
(E)-3-(3,4-Dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide
CAS:2505001-62-5
Formula:
C16H19Cl2N3O4S
Purity:
95%
Color and Shape:
Solid
Molecular weight:
420.3108
Ref: IN-DA01XBU4
| 5mg | 131.00 € | ||
| 10mg | 163.00 € | ||
| 25mg | 190.00 € | ||
| 50mg | 303.00 € | ||
| 200mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
SR18662 free base
CAS:2505001-62-5
SR18662, a KLF5 inhibitor derived from ML264, blocks colorectal cancer growth.
Formula:
C16H19Cl2N3O4S
Purity:
98.97%
Color and Shape:
Solid
Molecular weight:
420.31
Ref: TM-T9307
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 200mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information | |
| 1ml*10 (DMSO) | Discontinued | Request information | |
| 1mL*10mM (DMSO) | Discontinued | Request information |
